HBSP (USA)
-
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315045-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €8.20
-
Caso de estudio: Un inversionista ngel con una agenda personal
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103MEntrepreneurshipGloria Londoño, el dueño de una cadena de centros de día innovadoras e integrales para las personas mayores en España, se ofrece 3 millones de euros por Victor Serna, un acaudalado médico-inversor. A cambio, Serna quiere una participación del 25%, un puesto en la junta, un voto en todas las decisiones estratégicas, y la posibilidad de liquidar su posición en cinco años, ya sea a través de una oferta pública o una venta. Sus términos no son negoci...Starting at €8.20
-
Lehman Brothers
Nicholas, Tom; Chen, DavidCase HBS-810106-EEntrepreneurshipIn 2008, the U.S. financial system was in a state of crisis and Lehman Brothers went from a major Wall Street investment bank to an insolvent institution. It was a swift end for a firm that had its beginnings over 150 years prior. What would be the firm's legacy? And how, if at all, had its activities changed the course of American history?Starting at €8.20
-
An Angel Investor with an Agenda (HBR Case Study)
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103X-EEntrepreneurshipGloria Londono, the owner of a chain of innovative, holistic day care centers for the elderly in Spain, is offered 3 million euro by Victor Serna, a wealthy physician-investor. In exchange, Serna wants a 25% stake, a board seat, a vote on all strategic decisions, and the ability to liquidate his position in five years, either through a public offering or a sale. His terms are not negotiable; his objectives are not transparent. The money would ena...Starting at €8.20
-
The Global Sight Initiative
Herzlinger, Regina E.Case HBS-311034-EEntrepreneurshipHow to replicate a 'one of' social entrepreneurship effort: To cure blindness, Seva took the Aravind Eye Hospital & scaled it up to 100 hospitals globally.Starting at €8.20
-
The American Dream in History
Nicholas, Tom; Chen, DavidCase HBS-808134-EEntrepreneurshipStarting at €8.20
-
Dot.com: Online Pet Retailing
Nicholas, Tom; Chen, DavidCase HBS-809117-EEntrepreneurshipFrom 1995 to 1999, the U.S. experienced a period of tremendous growth in its information technology (IT) sector. The IT industry, although it accounted for less than 10% of the U.S. economy's total output, contributed disproportionately to economic growth. One market that was particularly contentious was online pet supply retailing. Pet supply retailing had an estimated worth of $31 billion in 1997, and in the late 1990s, several startups and bri...Starting at €8.20
-
Al Capone
Nicholas, Tom; Chen, DavidCase HBS-809144-EEntrepreneurshipIn 1929, Chicago, IL mob boss Al Capone was at the height of his power. As head of the extensive crime organization known as "The Outfit" during most of U.S.'s Prohibition Era (1920-1933), Capone oversaw hundreds of brothels, speakeasies, and roadhouses which served as venues for gang-administered gambling, prostitution, and illegal alcohol sales. At their peak, yearly revenues from all of his enterprises combined totaled over $100 million. Capon...Starting at €8.20
-
Crosley
Nicholas, Tom; Chen, DavidCase HBS-809160-EEntrepreneurshipIn October 1941, a top secret envoy from the U.S. military was sent to Crosley Corporation in Cincinnati, Ohio to request their assistance to construct a weapon that would drastically strengthen the defenses of U.S. troops: the proximity fuze. Such a fuze would allow enemy aircraft to be shot down with a rate of accuracy well above that of previous weaponry. The task would be a challenging one, as conventional wisdom held that it took at least fo...Starting at €8.20
-
Kleiner-Perkins and Genentech: When Venture Capital Met Science
Hardymon, G. Felda; Nicholas, TomCase HBS-813102-EEntrepreneurshipGenentech is a rare success story in the biotechnology industry. Hundreds of billions of dollars of venture capital have been invested without the expected transformational effects. Established in 1976, Genentech was to develop the new science of recombinant DNA into viable therapeutic products with mass market appeal, something that most scientists agreed was at least a decade away. The founders, Herbert Boyer and Robert Swanson had limited fina...Starting at €8.20